General Prognostics - GPx

📣2023 SXSW Pitch Finalist General Prognostics (GPx)📣

Proud of the at for being recognized and selected as one of the five SXSW Pitch Finalists among a group of from across the world🌍

SXSW Pitch is the marquee event of Conference & Festivals (March 10 - 19, 2023). We are honored and grateful for the opportunity to present and share our vision of at !

Congratulations to all the and see you in Austin👋

2023 SXSW Pitch Finalists Announced Explore finalists and alternates announced for the 15th annual SXSW Pitch event from March 11-12 in Austin, TX.

We've got huge news! We are incredibly excited to announce our funding round with support from incredible investors such as Peter Moran (former long-time GP of DCM Ventures), Hiroaki Kitano (CTO of Sony Group Corporation), Masao Hitotsuyanagi (former President of Terumo Cardiovascular), and Tom Kelley/D4V (Design for Ventures), alongside with many many investors. Thank you!

We are truly blessed to have employees, investors, partners, and supporters who believe in our vision of developing for cardio renal disease.

We still have a lot of work to do to accelerate the on-going pilot to further train and refine the algorithm but we are excited to continue this journey with you all.

The GPx Tribe deserves a mention - Soumil Chugh, Amit Singh, Kristy Osorez, Farheen Shaikh, Nandini Murthy, Theresa Tribble, Peter Branecky, Andrew J. Sauer, MD, Jim Yearick, John L Brooks III, Yusuke Tsugawa, MD, PhD, Sean Yokomizo.

Remote Patient Monitoring Could Solve Health Care’s Biggest Problems. So Why Hasn’t It? Medical device startup General Prognostics raised $3.25 million in seed funding to launch a wearable monitoring device. It’s one of several startups diving into remote patient monitoring.

We are thrilled to announce the appointment of Dr. Yusuke Tsugawa as a strategic advisor to GPx. Dr. Tsugawa is an associate professor of medicine and health policy & management at UCLA. His strategic perspective, thorough understanding of AI. and proven experience advising digital health companies will be valuable assets to guide GPx's algorithm development plan.

“We are excited to welcome Dr. Tsugawa as an advisor. He is a renowned expert in healthcare data and poise us to continue our development strategy that will enable the bloodless blood tests.” said Sean (Shunsuke) Matsuoka.